Skip to main

Top Losers

Last updated Jan 13, 2026 at 8:43 AM

Discover today’s top-losing stocks with real-time data to help investors and traders stay informed on the latest market shifts. This data includes the 50 US-listed stocks with the steepest losses, with key financial metrics like daily change, market cap, trading volume, and daily highs and lows.

Invest in stocks and more on Public

Public is an all-in-one investing platform where you can build a multi-asset portfolio that includes everything from stocks and options to bonds, crypto, and a High-Yield Cash Account.

Sign up now
NamePriceChangeMarket CapVolumeAnalyst RatingHigh TodayLow Today
NBY
NovaBay Pharmaceuticals
$13.45-29.80%1.7B3.01M$17.39$12.13
Trade
LXEO
Lexeo Therapeutics Inc
$8.12-22.96%592.66M5.17M$9.60$6.90
ATEC
Alphatec Hlds
$17.59-22.34%2.62B13.65M$21.56$17.43
THH
Tryhard Holdings Ltd
$23.10-21.61%1.48B183.38K$30.52$21.69
DGNX
Diginex Ltd
$2.42-21.43%488.72M2.68M$3.11$2.38
NUVB
Nuvation Bio
$6.46-19.65%2.23B15.6M$7.70$6.32
CLNN
Clene Nanomedicine
$5.18-19.00%53.54M380.6K$6.68$5
OPAD
Offerpad Solutions
$1.78-18.72%65.62M10.56M$1.91$1.77
SEV
Aptera Motors Corp
$3.99-18.41%134.57M483.51K$4.82$3.91
AZI
Autozi Internet Technology Global Ltd
$2.62-17.87%267.72M441.78K$3.13$2.56
ANF
Abercrombie & Fitch
$102.78-17.69%4.72B6.62M$106.20$98.80
AUTL
Autolus Therapeutics
$1.50-17.13%399.22M6.82M$1.79$1.49
PRLD
Prelude Therapeutics
$2.20-16.35%124.56M1.47M$2.67$2.10
CATX
Perspective Therapeutics Inc
$2.41-15.14%179.16M3.83M$2.89$2.33
APLS
Apellis Pharma
$23.20-15.02%2.94B5.26M$26.55$22.37
SIDU
Sidus Space
$3.41-14.96%261.77M44.71M$4.03$3.37
OESX
Orion Energy Systems
$14.51-14.65%51.24M82.62K$16.95$14
FBYD
Falcon's Beyond Global Inc
$9.78-13.98%473.45M100.32K$11.24$9.78
GOVX
Geovax Labs
$3.57-13.77%154.6M469.48K$4.40$3.24
SMMT
Summit Therapeutics
$17.04-13.42%14.62B8.8M$19.90$16.47
SPRY
ARS Pharmaceuticals Inc
$11.38-12.86%1.3B3.97M$13.15$11.20
DBGI
Digital Brands Group Inc
$14.83-12.59%121.4M287.59K$17.44$14.39
SIBN
SI-BONE Inc
$17.87-12.57%886.92M1.68M$20.29$17.73
BBNX
Beta Bionics Inc
$17.65-12.36%777.04M2.93M$20.31$17.42
URBN
Urban Outfitters
$71.52-12.31%7.32B4.71M$75.82$70.30
PEPG
PepGen Inc
$5.68-12.21%390.49M848.88K$6.45$5.57
WGS
GeneDx Holdings Corp
$119.24-11.92%3.92B2.15M$133$114.06
FLYX
flyExclusive Inc
$5.63-11.89%116.87M2.69M$7.20$4.92
INGN
Inogen
$6.21-11.66%168.6M613.05K$6.75$6
RNAC
Cartesian Therapeutics Inc
$7.27-11.34%189.05M162.99K$8.20$7.21
SRPT
Sarepta Therapeutics
$21.14-11.29%2.5B6.6M$24.05$20.21
MESO
Mesoblast
$18.67-10.93%2.4B560.17K$19.35$18.19
SHMD
SCHMID Group NV
$7.64-10.85%417.26M484.73K$8.75$7.35
BFH
Bread Financial Holdings Inc
$71.78-10.68%3.28B2.4M$73.80$70.06
STOK
Stoke Therapeutics Inc
$29.42-10.44%1.88B1.97M$29.49$25.21
XOMA
XOMA
$26.79-10.25%369.64M837.8K$29.57$24.40
AQST
Aquestive Therapeutics Inc
$3.51-10.23%428.24M13.78M$3.91$3.49
CAI
CAI
$25.60-10.21%7.23B4.81M$29$25.30
HQY
HealthEquity
$84.56-10.19%7.23B2.31M$91.34$84.44
FIGR
Figure Technology Solutions, Inc.
$52.23-10.07%11.18B6.38M$58.67$49.10
DAVE
Dave
$215.51-9.96%2.92B878.24K$250.20$213.41
PGEN
Precigen
$4.14-9.91%1.47B5.98M$4.59$4.10
DRCT
Direct Digital Holdings
$2.24-9.90%70.99M984.45K$2.98$2.09
CVRX
CVRx
$7.31-9.86%191.6M323.08K$8.15$6.96
PASG
PASSAGE BIO
$17.91-9.77%55.89M82.44K$19.95$17.28
KLRS
Allovir Inc
$8.84-9.61%165.33M174.13K$9.97$8.72
ATLC
Atlanticus Holdings
$59.72-9.52%904.26M108.56K$62.63$59.22
IMRX
Immuneering Corp
$4.22-9.35%272.49M4.42M$4.61$4.15
TNGX
Tango Therapeutics
$10.66-9.28%1.59B2.19M$11.65$10.37
ATRC
AtriCure
$37.64-9.21%1.88B903.13K$41.96$36.76

*Analyst Ratings available to Premium Members only.

Market data by Xignite. In order to offer the best user experience, certain criteria were applied - Stocks with a market capitalization of less than 50 million, All OTC (over-the-counter) stocks, penny stocks (trading below $1 value), as well as stocks with an average daily volume of less than 10,000 over the past three months or less than 100,000 intraday volume were excluded from the dataset.

Please note that while we strive to provide accurate and up-to-date information, stock prices and other data may fluctuate and should be verified independently. We encourage users to conduct thorough research before making any investment decisions based on the information provided.